| 000 | 01637 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513160119.0 | ||
| 264 | 0 | _c19990322 | |
| 008 | 199903s 0 0 eng d | ||
| 022 | _a0022-0795 | ||
| 024 | 7 |
_a10.1677/joe.0.1600111 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLea, C K | |
| 245 | 0 | 0 |
_aOvarian androgens protect against bone loss in rats made oestrogen deficient by treatment with ICI 182,780. _h[electronic resource] |
| 260 |
_bThe Journal of endocrinology _cJan 1999 |
||
| 300 |
_a111-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aAnilides _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAromatase _xgenetics |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 |
_aEstradiol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFulvestrant |
| 650 | 0 | 4 |
_aInterleukin-6 _xgenetics |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aOrgan Size _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aTosyl Compounds |
| 650 | 0 | 4 |
_aUterus _xanatomy & histology |
| 700 | 1 | _aFlanagan, A M | |
| 773 | 0 |
_tThe Journal of endocrinology _gvol. 160 _gno. 1 _gp. 111-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1677/joe.0.1600111 _zAvailable from publisher's website |
| 999 |
_c9821930 _d9821930 |
||